Table 2 Spirometry and pharmacologic management of COPD
Spirometry and Pharmacologic Management of COPD | ||||
|---|---|---|---|---|
Group A | Group B | Group C | Group D | |
Medications | ||||
SABA | 18.86% | 6.95% | 3.85% | 4.29% |
LAMA only | 0.00% | 0.00% | 3.85% | 2.86% |
LABA only | 7.12% | 6.73% | 7.69% | 3.33% |
ICS + LABA | 24.20% | 17.92% | 15.38% | 15.71% |
LAMA + LABA | 17.79% | 19.00% | 34.62% | 10.00% |
LAMA + LABA + ICS | 30.60% | 47.77% | 30.77% | 63.33% |
ICS only | 1.42% | 1.19% | 3.85% | 0.48% |
ICS + LAMA | 0.00% | 0.43% | 0.00% | 0.00% |
Spirometry, n (%) | ||||
Mild: FEV1 ≥ 80 | 70 (25) | 202 (22) | 6 (23) | 39 (19) |
Moderate: 50 ≥ FEV1 < 80 | 145 (52) | 470 (51) | 13 (50) | 106 (50) |
Severe: 30 ≥ FEV1 < 50 | 51 (18) | 193 (21) | 5 (19) | 47 (22) |
Very severe: < 30 | 15 (5) | 55 (6) | 2 (8) | 18 (9) |